1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,033 | 0,039 | 17:15 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Lifecare ASA Q3 Loss Narrows | 11 | RTTNews | ||
| Do | LIFE: Lifecare ASA Q3 2026 results | 1 | Oslo Børs | ||
| 06.11. | LIFECARE ASA: NOTIFICATION OF MAJOR HOLDINGS | 2 | Oslo Børs | ||
| 05.11. | Lifecare ASA (LIFE): Invitation to Q3 2026 results presentation | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 26.10. | LIFECARE ASA: Lifecare advances rapidly towards repeatable in-house implant manufacturing at new Bergen facilities | 1 | Oslo Børs | ||
| 30.09. | LIFECARE ASA: Mandatory Notification of Trade by Primary Insider | 3 | Oslo Børs | ||
| 29.09. | LIFECARE ASA: Lifecare successfully manufactures first functional implants in-house in Bergen | 4 | Oslo Børs | ||
| 15.09. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 31.08. | Lifecare ASA acquires 80% of Ocean TuniCell securing established GMP manufacturing infrastructure in Bergen | 4 | Oslo Børs | ||
| 31.08. | OCEAN GEOLOOP ASA: Captured AS enters into agreement to sell its shares in its subsidiary Ocean Tunicell AS to Lifecare ASA | 2 | Oslo Børs | ||
| 19.08. | LIFE: Lifecare ASA Q2 2026 results | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST | 1 | Oslo Børs | ||
| 02.07. | Lifecare ASA: LIFE: Update on production transfer and longevity programme | 2 | Oslo Børs | ||
| 26.06. | Lifecare ASA: LIFE: Operational update regarding Lifecare Germany GmbH (i.L) | 4 | Oslo Børs | ||
| 22.06. | Lifecare ASA: Share capital increase registered | 6 | Oslo Børs | ||
| 22.06. | Lifecare ASA: LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation | 3 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue | 6 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 3 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Mandatory notification of trade | 2 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response | 1 | Oslo Børs |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,067 | -3,75 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 40,180 | +0,45 % | Bear of the Day: Boston Scientific (BSX) | ||
| PAUL HARTMANN | 187,00 | -1,84 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 12,040 | +1,82 % | Sysmex Corporation H1 Profit Drops | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) released earnings for first half that Dropped, from the same period last yearThe company's bottom line came in at JPY17.933 billion, or JPY29.47... ► Artikel lesen | |
| ADDLIFE | 16,280 | -1,33 % | AddLife AB: AddLife acquires MoonSurge | AddLife has acquired MoonSurge, Importação e Exportação de Material Médico, LDA, a leading Portuguese distributor of high-quality medical devices for advanced surgery. MoonSurge will become an independent... ► Artikel lesen | |
| EMBECTA | 5,790 | -0,38 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ENOVIS | 25,400 | +1,60 % | Enovis stock price target reaffirmed at $42 by BTIG on growth | ||
| PULMONX | 2,620 | 0,00 % | Pulmonx auf der Stifel 2026 Healthcare Conference: Strategische Neuausrichtung gewinnt an Dynamik | ||
| SI-BONE | 21,600 | 0,00 % | SI-BONE, Inc.: SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx, Extending Its Compromised Bone Franchise Beyond the Pelvis | SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,414 | -3,27 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| KOOTH | 2,180 | +0,93 % | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | ||
| BACTIGUARD | 1,160 | 0,00 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2026 | Accelerating performance validates our partnership model
Third quarter 2026 (July - September)Total revenue amounted to SEK 58.4 (48.4) million, an increase of SEK 10.0 million corresponding to 20.6%.Net... ► Artikel lesen | |
| SCIBASE | 0,860 | 0,00 % | SciBase: Interim report | SciBase: Interim report
January 1 - September 30, 2026STOCKHOLM, Nov. 12, 2026 /PRNewswire/ --
The third quarter in figuresNet sales were TSEK 14,621 (10,339), +41%, cleared for currency effects... ► Artikel lesen | |
| PHC HOLDINGS | 6,800 | -4,23 % | PHC Holdings Q2 FY2026 slides: profit surges 87% on diabetes strength | ||
| FRESENIUS MEDICAL CARE | 40,110 | +1,39 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 38 auf 37,50 Euro gesenkt und die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen |
Das Unternehmen LIFECARE ASA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,039 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.